ADVERTISEMENT

New Science

ADCs, New Modalities High On Korea State Fund’s Priorities

ADCs, New Modalities High On Korea State Fund’s Priorities

While oncology and discovery-stage assets accounted for the majority of R&D projects supported by a Korean state fund this year, new modalities such as ADCs and TPDs are emerging.

Kenvue Vaping Cessation Study: Nicorette QuickMist Provides ‘Significant And Fast’ Relief

Kenvue Vaping Cessation Study: Nicorette QuickMist Provides ‘Significant And Fast’ Relief

Use of Kenvue’s Nicorette QuickMist nicotine replacement therapy device resulted in “statistically significant reductions in urges to vape as soon as 30 seconds and up to two hours after dosing compared with placebo,” according to a recently published study funded by the firm.

Tobacco Giant Philip Morris Sells Medical Device Business, Keeps Consumer Health Footprint

Tobacco Giant Philip Morris Sells Medical Device Business, Keeps Consumer Health Footprint

Philip Morris described a scenario of being essentially blacklisted by the health care sector and its CDMO partners as it threw in the towel on its £1.1bn acquisition of UK inhalation specialist Vectura. It agreed to offload the firm at a fraction of the initial cost.

Tobacco Giant Philip Morris Sells Medical Device Business, Keeps Consumer Health Footprint

Tobacco Giant Philip Morris Sells Medical Device Business, Keeps Consumer Health Footprint

Philip Morris described a scenario of being essentially blacklisted by the health care sector and its CDMO partners as it threw in the towel on its £1.1bn acquisition of UK inhalation specialist Vectura. It agreed to offload the firm at a fraction of the initial cost.

AstraZeneca/Daiichi Make Their Case For Dato-DXd In Non-Squamous Lung Cancer

AstraZeneca/Daiichi Make Their Case For Dato-DXd In Non-Squamous Lung Cancer

Data at WCLC showed why the TROP2-targeting ADC datopotamab deruxtecan is most effective in non-squamous NSCLC in second or later lines as presented in overall survival data at the meeting.

Over The Counter: Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland

Over The Counter: Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland

In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry. 

Freely Available Microbiome Data ‘Atlas’ Could Provide Industry Boost

Freely Available Microbiome Data ‘Atlas’ Could Provide Industry Boost

King’s College London has released a freely available ‘Human Gut Microbiome Atlas’ to help researchers better understand how microorganisms in the gut impact disease. 

Study: OTC Nasal Sprays Reduce Respiratory Illness Duration And Help Tackle AMR

Study: OTC Nasal Sprays Reduce Respiratory Illness Duration And Help Tackle AMR

A recently-published study funded by the UK National Institute for Health and Care Research finds that use of OTC nasal sprays reduces overall respiratory illness duration by about a fifth. Applied at a population level, self-care could therefore save billions in healthcare and human capital costs, as industry has pointed out elsewhere, as well as redirecting people away from antibiotic treatments that are still widely misprescribed, contributing to the fight against antimicrobial resistance. 

Formation Secures Huge Series D For AI Platform Growth

Formation Secures Huge Series D For AI Platform Growth

Biopharmaceutical venture capital fundraising is on the rise in 2024. In late June, Formation Bio secured a mega financing, raising $372m via a series D round led by a16z and Sanofi. 

CHC Industry Must Do More To Help Consumers Age Healthily, Especially Women

CHC Industry Must Do More To Help Consumers Age Healthily, Especially Women

Consumer health companies need to meet consumers where they are in their life-stage journeys, providing healthy aging solutions like dietary supplements that have clearly communicated and science-backed benefits, argued panelists at a recent IQVIA Consumer Health webinar. This is particularly the case for women, who are underserved and want natural support for changes like the menopause, said Haleon's Sheryl Tan.